BRAVO
BRAVO BIG 5-13 Share This Post Niraparib for patients with HER2-negative, germline BRCA mutation-positive, locally advanced or metastatic breast cancer For more information please visit
EURECA
EURECA, a European project, aimed to close the gap identified in healthcare IT infrastructures by building software solutions to improve interoperability among existing data systems.
Despite improvements in healthcare IT infrastructures, a gap was identified in the ability of these systems to deliver knowledge and insight back to the researchers, clinicians, and patients they are intended to support. EURECA, a European project, aimed to close this gap by building software solutions to improve interoperability among existing data systems, such as clinical trials and electronic health record systems.
EURECA covered technological, medical and legal research, service development, large-scale system integration, testing, and uptake activities in a complex interaction.
More specifically the following tasks were defined:
·      Scenarios of user behaviour and interaction with platform functionality is an extremely useful instrument for identifying key technological, security, socio-economic and business drivers for future user requirements of new work methods and collaborative work environments. The created scenarios were deduced from the domain settings defined by users and provided the framework for all subsequent user requirements specifications.
·      Functional user requirements specifications based on the user scenarios involved addressing seamless interoperability, openness, and specific user requirements for the selected user cases also had to be integrated in the functional requirement specification.
·      Trust and security user requirements specifications involved identifying not only trust and security issues, but also legal and ethical issues, which in turn translated into new trust and security requirements.
·      Societal user requirement specifications done by correlating ethical, regulatory and policy issues with the deployment and wide-spread use of the EURECA environment and services. Aspects of social acceptance, regulatory frameworks for surveillance and control of private citizens, privacy of data, governmental provisions, and other such challenges were addressed and integrated with the functional and trust and security user requirement.
Led by Philips Electronics, the initiative brought together 18 partner organisations from Europe and Canada with the technical and clinical expertise to create these unique IT solutions.
The project started on 01/02/2012 for a period of 42 months.
The initiative involved 18 partner organisations from Europe and Canada, among them BIG
EURECA was funded by a grant from the European Commission’s FP7-ICT programme (FP7-ICT-2010-288048).
BRAVO BIG 5-13 Share This Post Niraparib for patients with HER2-negative, germline BRCA mutation-positive, locally advanced or metastatic breast cancer For more information please visit
AMEERA-6 BIG 20-01 Share This Post A randomized, multicentre, double-blind, phase 3 study of amcenestrant (SAR439859) versus tamoxifen for the treatment of patients with hormone
Les dons supérieurs ou égaux à 40 € par an bénéficient d'une réduction d'impôt de 45 %. Cela signifie que votre don de 40 € ne vous coûte que 22 €.
The Breast International Group is proud to adhereto the Code of Ethics of the du VEF-AERF
Cofinancé par l'Union européenne dans le cadre d'une subvention de fonctionnement du programme EU4Health de l'Union européenne au titre de l'accord de subvention n° 101124555. Les points de vue et avis exprimés n’engagent toutefois que leur(s) auteur(s) et ne reflètent pas nécessairement ceux de l’Union européenne ou de l’Agence exécutive européenne pour la santé et le numérique (HADEA). Ni l’Union européenne ni HADEA ne sauraient en être tenues pour responsables.